Insilico Medicine 1 article

AI drug discovery and Pharma AI platform define the computational life-science profile of Insilico Medicine, a computational biotechnology company. Its biotechnology relevance comes from combining generative chemistry for small molecules and AI target discovery, with generative molecular design connecting model output to discovery decisions in molecular or translational research. For entity matching, computational outputs and therapeutic programs are mapped independently; Insilico Medicine is also associated with deep learning for drug discovery.